Antibodies to domain I of β-2-glycoprotein I and IgA antiphospholipid antibodies in patients with 'seronegative' antiphospholipid syndrome

被引：40
|
作者：
Cousins, Laura [1 ]
Pericleous, Charis [1 ]
Khamashta, Munther [2 ]
Bertolaccini, Maria Laura [2 ]
Ioannou, Yiannis [1 ,3 ]
Giles, Ian [1 ]
Rahman, Anisur [1 ]
机构：
[1] UCL, Ctr Rheumatol Res, London, England
[2] Kings Coll London, Sch Med, Lupus Res Unit, London WC2R 2LS, England
[3] UCL, Arthrit Res UK Ctr Adolescent Rheumatol, London, England
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2015年 / 74卷 / 01期
关键词：
ANTIGENIC TARGET;
D O I：
10.1136/annrheumdis-2014-206483
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：317 / U444
页数：3
相关论文
共 50 条
  • [1] Clinical assessment of antiphospholipid antibodies against β2-glycoprotein domain I in antiphospholipid syndrome
    Marco, P.
    Marco, A.
    Cabrera, V
    Gonzalez, V
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 282 - 283
  • [2] Oxidation of β2-glycoprotein I associates with IgG antibodies to domain I in patients with antiphospholipid syndrome
    Raimondo, Maria Gabriella
    Pericleous, Charis
    Radziszewska, Anna
    Borghi, Maria Orietta
    Pierangeli, Silvia
    Meroni, Pier Luigi
    Giles, Ian
    Rahman, Anisur
    Ioannou, Yiannis
    PLOS ONE, 2017, 12 (10):
  • [3] Anti-β2-glycoprotein I antibodies and the antiphospholipid syndrome
    Li, Z
    Krilis, SA
    AUTOIMMUNITY REVIEWS, 2003, 2 (05) : 229 - 234
  • [4] Antibodies to Domain I β2-Glycoprotein 1 in Patients with Antiphospholipid Syndrome and Systemic Lupus Erythematosus
    Reshetnyak, T. M.
    Cheldieva, F. A.
    Cherkasova, M. V.
    Glukhova, S. I.
    Lila, A. M.
    Nasonov, E. L.
    DOKLADY BIOCHEMISTRY AND BIOPHYSICS, 2023, 511 (01) : 219 - 226
  • [5] Antibodies to Domain I β2-Glycoprotein 1 in Patients with Antiphospholipid Syndrome and Systemic Lupus Erythematosus
    T. M. Reshetnyak
    F. A. Cheldieva
    M. V. Cherkasova
    S. I. Glukhova
    A. M. Lila
    E. L. Nasonov
    Doklady Biochemistry and Biophysics, 2023, 511 : 219 - 226
  • [6] Avidity of anti-β2-glycoprotein I antibodies in patients with antiphospholipid syndrome
    Cucnik, S.
    Kveder, T.
    Artenjak, A.
    Gallova, Z. Ulcova
    Swadzba, J.
    Musial, J.
    Iwaniec, T.
    Stojanovich, L.
    Alessandri, C.
    Valesini, G.
    Avcin, T.
    Tervaert, J. W. Cohen
    Rozman, B.
    Bozic, B.
    LUPUS, 2012, 21 (07) : 764 - 765
  • [7] ANTIPHOSPHOLIPID ANTIBODIES AGAINST β-2 GLYCOPROTEIN I DOMAIN I IN ANTIPHOSPHOLIPID SYNDROME: ASSESSMENT BY CHEMOLUMINESCENCE
    Mauricio, A.
    Gonzalez, V.
    Marco, A.
    Puig, J.
    Marco, P.
    THROMBOSIS RESEARCH, 2014, 133 : S36 - S37
  • [8] β2-glycoprotein I and its antibodies involve in the pathogenesis of the antiphospholipid syndrome
    Bai, Aiping
    IMMUNOLOGY LETTERS, 2017, 186 : 15 - 19
  • [9] The clinical value of assays detecting antibodies against domain I of β2-glycoprotein I in the antiphospholipid syndrome
    Yin, Dongmei
    de Laat, Bas
    Devreese, Katrien M. J.
    Kelchtermans, Hilde
    AUTOIMMUNITY REVIEWS, 2018, 17 (12) : 1210 - 1218
  • [10] Domain I of β2-glycoprotein I ameliorates thrombosis induced by antiphospholipid antibodies in mice
    Iaonnou, J.
    Harper, T.
    Romay-Penabad, Z.
    Giles, I. P.
    Pericleous, C.
    Rahman, A.
    Liu, X.
    Pierangeli, S. S. S.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2007, 25 (02) : 162 - 162
12345